Patients with chronic fatigue syndrome benefit from cognitive behavior therapy

Researchers from Amsterdam UMC and King’s College London have shown that Cognitive Behavioral Therapy (CBT) is beneficial for those with ME/CFS.

U.K.’s cost-effectiveness agency says Alzheimer’s drug donanemab does not provide good value

LONDON — For the second time in a matter of months, the U.K.’s cost-effectiveness watchdog has said the limited benefits of a newly approved Alzheimer’s

October 23, 2024

Exscientia outline robot and AI use in drug discovery workflow – Pharmaceutical Technology

Martin Redhead presenting at the ELRIG Drug Discovery 2024 conference in London, UK. Credit: Jenna Philpott / GlobalData. As AI continues to disrupt the healthcare

October 2, 2024

Jury awards Natera $96M+ in blood test patent fight

CareDx said it will fight a $96 million jury verdict in the company’s years-long patent battle with Natera over their rival kidney transplant rejection tests.

January 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.